Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05346042Active Not Recruiting

Safe and Timely Cessation of Isolation of Patients With COVID-19 (The SCIP-COVID-19) Study

Role: collaborator

NCT03043820Phase 3Completed

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

Role: collaborator

NCT03169530Not ApplicableTerminated

Moderate Alcohol and Cardiovascular Health Trial

Role: collaborator

NCT01566812Not ApplicableUnknown

Effect of Breastfeeding Optimization on Early Vascular Development

Role: collaborator

NCT01877499Completed

Can High Convection Volumes be Achieved in Each Patient During Online Post-dilution Hemodiafiltration?

Role: collaborator

NCT01715116Not ApplicableUnknown

ENHANCED Device Programming to Reduce Therapies and Improve Quality of Life in Implantable Cardioverter Defibrillator (ICD) Patients

Role: collaborator

NCT01662323Phase 4Completed

Study to Improve the Treatment of Patients With Heart Failure by General Practitioners

Role: lead

All 7 trials loaded